HER2+ esophageal carcinoma leptomeningeal metastases treated with intrathecal trastuzumab regimen

Materials & methods: We recently reported the largest trial of breast cancer patients with HER2 positive leptomeningeal metastases (LM) treated with trastuzumab. An additional treatment indication was explored as part of a single institution retrospective case series of HER2 positive esophageal...

詳細記述

書誌詳細

出版年:	CNS Oncology
主要な著者:	Scott A Wu, Dan Tong Jia, Margaret Schwartz, Mary Mulcahy, Kuanghua Guo, Matthew C Tate, Sean Sachdev, Nicolas Kostelecky, David J Escobar, Daniel J Brat, Amy B Heimberger, Rimas V Lukas
フォーマット:	論文
言語:	英語
出版事項:	Taylor & Francis Group 2023-09-01
主題:	circulating tumor cells esophageal cancer HER2 intrathecal leptomeningeal metastases trastuzumab
オンライン･アクセス:	https://www.futuremedicine.com/doi/10.2217/cns-2022-0018